· Company introduces a top-tier team of chemists to lead innovation in hydrophilic coatings and develop cutting-edge, environmentally friendly solutions
· Restructured R&D division, under new leadership, aims to enhance product offerings, improve operational efficiency, and drive future growth
CONCORD, N.C. , Oct. 21, 2024 (GLOBE NEWSWIRE) -- Hydromer, Inc. (OTC: HYDI), a leader in hydrophilic coating technologies for medical and industrial applications for over 44 years, is excited to announce the formation of a new Research and Development (R&D) division. This restructuring introduces a world-class science team focused on innovation and performance, adding two Ph.D. chemists and one M.S. chemist. Leading the team is Dr. Yonghua Zhou, Ph.D. in Polymer Science from the University of Massachusetts at Lowell. Dr. Zhou brings an impressive background in polymer science, having led new product development activities at InnoPoly Biotech, Kraton Polymers, and Innovia LLC.
Joining Dr. Zhou in forming the company's new research and development team are Mr. Ashutosh Upadhyay and Ms. Mengxue Zhang. Mr. Upadhyay brings over 30 years of polymer science experience, including serving for more than 15 years as Senior Material Development Chemist at Dana Corporation. He holds an M.S. degree in Chemistry from Agra University (India). Ms. Zhang, a Ph.D. in Chemistry from the University of South Carolina, and M.S. in Polymer Engineering from the University of Akron, focused her studies on controlling nanoparticle distribution within polymer coatings. These new team members solidify the company's commitment to innovation and advanced product development.
Hydromer's Enhanced Focus on Innovation and Efficiency
Under its new executive leadership, Hydromer has refocused its efforts on improving financial reporting and record-keeping, enhancing operational efficiencies, and advancing the science behind its current and future coating technologies. Recognizing the need for both product improvement and innovation to meet customer demands, the company has assembled this highly credentialed team to revitalize legacy products and create new solutions for evolving market needs. With Dr. Zhou's experience and leadership, the R&D team aims to develop advanced coatings that are both more durable and environmentally friendly, addressing the growing regulatory restrictions surrounding harmful solvents.
"We are excited to introduce this new science team, which will reposition Hydromer as a leader in both product development and innovation,” said CEO Mike Torti. "While our hydrophilic coatings have provided a strong foundation, it's time to elevate our offerings - improving existing products and creating new technologies that meet today's industry demands. We anticipate that these developments will open new doors and markets for the company's growth.”
Hydromer's revitalized focus on R&D is expected to drive the creation of cutting-edge coating systems designed to improve lubricity and durability across a range of medical and industrial applications. With this strategic step, Hydromer not only aims to stay competitive but also to lead in developing solutions for the future.
About Hydromer
Hydromer, Inc. is an ISO 9001:2015 global business-to-business (B2B) surface modification and coating solutions provider offering polymer R&D and manufacturing services capabilities for a wide variety of applications. We are domiciled in Concord, NC. Our customers are located across the United States, Europe and Asia-Pacific. Our facilities are U.S. Food and Drug Administration (FDA), Good Manufacturing Practice (GMP), International Organization for Standardization (ISO) 13485, and International Organization for Standardization (ISO) 9001 compliant. For over four decades, the Company has developed value-added solutions to serve businesses in domestic and international markets in a wide range of industries. We manage numerous global B2B services such as coating services, research and development, analytical testing, technology transfer, and dedicated machinery building, installation, and support. We have successfully developed numerous proprietary formulations and hold patents worldwide.
Contact: [email protected]
Forward-Looking Statements
The statements contained in the above communication that are not historic facts are forward looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those set forth in or implied by forward-looking statements. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. Our actual results may differ materially from those contemplated by the forward-looking statements. They are neither statements of historical fact nor guarantees of assurance of future performance. We caution you therefore against relying on any of these forward-looking statements. For example, if our actual results differ materially from those contemplated by the forward-looking statements the trading price of our common stock could decline, and investors in our securities may lose all or part of their investment.
